XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 19 -- Income Taxes

A summary of income tax expense (benefit) is as follows:

 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

23,997

 

 

$

(3,853

)

 

$

2,332

 

State

 

 

5,431

 

 

 

(275

)

 

 

415

 

Foreign

 

 

67

 

 

 

194

 

 

 

102

 

Total current taxes

 

 

29,495

 

 

 

(3,934

)

 

 

2,849

 

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

(738

)

 

 

(7,828

)

 

 

489

 

State

 

 

(365

)

 

 

(2,023

)

 

 

653

 

Foreign

 

 

1

 

 

 

(30

)

 

 

 

Total deferred taxes

 

 

(1,102

)

 

 

(9,881

)

 

 

1,142

 

Income tax expense (benefit)

 

$

28,393

 

 

$

(13,815

)

 

$

3,991

 

 

The reasons for the differences between the statutory federal income tax rate and the effective tax rate are summarized as follows:

 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

Amount

 

 

%

 

 

Amount

 

 

%

 

 

Amount

 

 

%

 

Income taxes at statutory rate

 

$

24,706

 

 

 

21.0

 

 

$

(14,368

)

 

 

21.0

 

 

$

2,359

 

 

 

21.0

 

Increase (decrease) in income taxes
   resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

State income taxes, net of federal
   tax benefits

 

 

4,951

 

 

 

4.2

 

 

 

(2,812

)

 

 

4.1

 

 

 

402

 

 

 

3.6

 

Effects of tax rate changes

 

 

(155

)

 

 

(0.1

)

 

 

 

 

 

 

 

 

437

 

 

 

3.9

 

Stock-based compensation

 

 

(49

)

 

 

 

 

 

(431

)

 

 

0.6

 

 

 

(298

)

 

 

(2.7

)

Non-deductible executive compensation

 

 

1,035

 

 

 

0.9

 

 

 

1,252

 

 

 

(1.8

)

 

 

1,008

 

 

 

9.0

 

Change in valuation allowance

 

 

(2,549

)

 

 

(2.2

)

 

 

2,549

 

 

 

(3.7

)

 

 

 

 

 

 

Other

 

 

454

 

 

 

0.3

 

 

 

(5

)

 

 

 

 

 

83

 

 

 

0.7

 

Income tax expense (benefit)

 

$

28,393

 

 

 

24.1

 

 

$

(13,815

)

 

 

20.2

 

 

$

3,991

 

 

 

35.5

 

 

The Company has no uncertain tax positions or unrecognized tax benefits that, if recognized, would impact the effective income tax rates for the years ended December 31, 2023, 2022, and 2021. The tax returns filed for the years ending December 31, 2022, 2021, and 2020 remain subject to examination by the Company’s major taxing jurisdictions. The Company elected to classify interest and penalties, if any, arising from uncertain tax positions as income tax expense as permitted by current accounting standards. For the year ended December 31, 2023, the Company recognized approximately $150 of interest expense on underpayments related to income tax liabilities and classified that interest as income tax expense. There were no material amounts of interest or penalties for the years ended December 31, 2022 and 2021.

For the year ended December 31, 2023, the Company recorded $28,393 of income tax expense resulting in an effective tax rate of 24.1%. For the years ended December 31, 2022 and 2021, the Company recorded income tax benefit of $13,815 and income tax expense of $3,991, respectively, resulting in effective tax rates of 20.2% and 35.5%, respectively. The increase in the effective tax rate in 2023 as compared with 2022 was primarily attributable to the reversal of the valuation allowance established as of December 31, 2022.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

Significant components of the Company’s net deferred income tax assets (liabilities) are as follows:

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Deferred tax assets:

 

 

 

 

 

 

Unearned premiums

 

$

19,378

 

 

$

12,588

 

Losses and loss adjustment expenses

 

 

3,331

 

 

 

3,013

 

Stock-based compensation

 

 

1,878

 

 

 

1,570

 

Unearned revenue

 

 

1,089

 

 

 

426

 

Net unrealized investment losses

 

 

732

 

 

 

428

 

Basis difference related to convertible senior notes

 

 

516

 

 

 

300

 

Accrued expenses

 

 

175

 

 

 

163

 

Credit losses

 

 

156

 

 

 

244

 

Organizational costs

 

 

116

 

 

 

128

 

Bad debt reserve

 

 

16

 

 

 

44

 

Net operating loss carryforwards

 

 

 

 

 

13,883

 

Other

 

 

17

 

 

 

85

 

Total deferred tax assets

 

 

27,404

 

 

 

32,872

 

Valuation allowance

 

 

 

 

 

(2,549

)

Total deferred tax assets, net of valuation allowance

 

 

27,404

 

 

 

30,323

 

Deferred tax liabilities:

 

 

 

 

 

 

Gain on involuntary conversion

 

 

(11,460

)

 

 

(12,500

)

Deferred policy acquisition costs

 

 

(11,272

)

 

 

(12,156

)

Basis difference related to partnership investments

 

 

(2,249

)

 

 

(2,942

)

Prepaid expenses

 

 

(573

)

 

 

(703

)

Intangible assets

 

 

(541

)

 

 

(1,878

)

Property and equipment

 

 

(271

)

 

 

(1,515

)

Other

 

 

(526

)

 

 

(333

)

Total deferred tax liabilities

 

 

(26,892

)

 

 

(32,027

)

Net deferred tax assets (liabilities)

 

$

512

 

 

$

(1,704

)

The Company has zero federal net operating loss carryforwards available as of December 31, 2023. The Company has zero state net operating loss carryforwards available as of December 31, 2023.

A valuation allowance must be established for deferred tax assets when it is more likely than not that the deferred tax assets will not be realized based on available evidence both positive and negative, including recent operating results, available tax planning strategies, and projected future taxable income. As of December 31, 2023, management concluded, based on the evaluation of the positive and negative evidence, that is more likely than not that the deferred tax assets will be realized and therefore no valuation allowance on the Company’s deferred tax assets is required. As of December 31, 2022, a $2,549 valuation allowance was established as management concluded it was more likely than not that the deferred tax assets would not be realized based on an evaluation of the positive and negative evidence.